Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests

Aishwarya Soni,Astha Guliani,Kiran Nehra,Promod K. Mehta
DOI: https://doi.org/10.1080/17476348.2022.2093189
2022-07-07
Expert Review of Respiratory Medicine
Abstract:Pleural tuberculosis (TB) is the archetype of extrapulmonary TB (EPTB), which mainly affects the pleural space and leads to exudative pleural effusion. Diagnosis of pleural TB is a difficult task predominantly due to atypical clinical presentations and sparse bacillary load in clinical specimens. We reviewed the current literature on the globally existing conventional/latest modalities for diagnosing pleural TB. Bacteriological examination (smear/culture), tuberculin skin testing/interferon-γ release assays, biochemical testing, imaging and histopathological/cytological examination are the main modalities. Moreover, nucleic acid amplification tests (NAATs), i.e . loop-mediated isothermal amplification, PCR/multiplex-PCR, nested-PCR, real-time PCR and GeneXpert ® MTB/RIF are being utilized. Currently, GeneXpert Ultra, Truenat MTB TM , detection of circulating Mycobacterium tuberculosis ( Mtb ) cell-free DNA by NAATs, aptamer-linked immobilized sorbent assay and immuno-PCR (I-PCR) have also been exploited. Routine tests are not adequate for effective pleural TB diagnosis. The latest molecular/immunological tests as discussed above, and the other tools, i.e . real-time I-PCR/nanoparticle-based I-PCR and identification of Mtb biomarkers within urinary/serum extracellular vesicles being utilized for pulmonary TB and other EPTB types may also be explored to diagnose pleural TB. Reliable diagnosis and early therapy would reduce the serious complications associated with pleural TB, i.e . TB empyema, pleural fibrosis, etc.
respiratory system
What problem does this paper attempt to address?